Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-hydroxy-5h-pyrido-(3,2-a)-phenoxazin-5-one-3-carboxylic Acid
2. Catalin
3. Pirenoxine, Sodium Salt
1. 1043-21-6
2. 1,5-dioxo-4h-pyrido[3,2-a]phenoxazine-3-carboxylic Acid
3. Catalin-k
4. 27l0ep6izk
5. 5h-pyrido[3,2-a]phenoxazine-3-carboxylicacid, 1-hydroxy-5-oxo-
6. 1-hydroxy-5-oxopyrido[3,2-a]phenoxazine-3-carboxylic Acid
7. Pirenoxina
8. Pirenoxinum
9. 1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylic Acid;1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylic Acid
10. Prx
11. Pirenoxinum [latin]
12. Pirenoxina [spanish]
13. Pirenoxine [inn:jan]
14. Unii-27l0ep6izk
15. Catalin
16. Einecs 213-872-4
17. Catalin-k (tn)
18. Pirenoxine [mi]
19. Pirenoxine [inn]
20. Pirenoxine [jan]
21. Pirenoxine (jp17/inn)
22. Pirenoxine [who-dd]
23. Schembl36173
24. Chembl1372341
25. Dtxsid6048335
26. Schembl22360205
27. Chebi:32013
28. Zinc11616009
29. Akos015888305
30. Am84317
31. Bs-42378
32. Db-040533
33. Ft-0603540
34. D01100
35. 043p216
36. A800955
37. Q7197959
38. 1-hydroxy-5-oxo-5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid
39. 4-hydroxy-12-oxo-12h-10-oxa-1,5-diazatetraphene-2-carboxylic Acid
40. 5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid, 1-hydroxy-5-oxo-
| Molecular Weight | 308.24 g/mol |
|---|---|
| Molecular Formula | C16H8N2O5 |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 1 |
| Exact Mass | 308.04332136 g/mol |
| Monoisotopic Mass | 308.04332136 g/mol |
| Topological Polar Surface Area | 105 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 771 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Global Sales Information
ABOUT THIS PAGE
A Pirenoxine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pirenoxine, including repackagers and relabelers. The FDA regulates Pirenoxine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pirenoxine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pirenoxine supplier is an individual or a company that provides Pirenoxine active pharmaceutical ingredient (API) or Pirenoxine finished formulations upon request. The Pirenoxine suppliers may include Pirenoxine API manufacturers, exporters, distributors and traders.
Pirenoxine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pirenoxine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pirenoxine GMP manufacturer or Pirenoxine GMP API supplier for your needs.
A Pirenoxine CoA (Certificate of Analysis) is a formal document that attests to Pirenoxine's compliance with Pirenoxine specifications and serves as a tool for batch-level quality control.
Pirenoxine CoA mostly includes findings from lab analyses of a specific batch. For each Pirenoxine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pirenoxine may be tested according to a variety of international standards, such as European Pharmacopoeia (Pirenoxine EP), Pirenoxine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pirenoxine USP).
LOOKING FOR A SUPPLIER?
